USANA Health Sciences (NYSE:USNA) Issues Quarterly Earnings Results, Beats Estimates By $0.15 EPS

USANA Health Sciences (NYSE:USNA) issued its quarterly earnings results on Tuesday. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.15, Zacks reports. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The firm had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.

USANA Health Sciences Stock Performance

Shares of USNA stock traded down $3.82 during trading hours on Thursday, hitting $29.39. The company had a trading volume of 91,313 shares, compared to its average volume of 150,236. USANA Health Sciences has a 12 month low of $29.50 and a 12 month high of $50.32. The firm has a market capitalization of $560.19 million, a price-to-earnings ratio of 10.44, a PEG ratio of 0.93 and a beta of 0.87. The firm’s fifty day moving average is $33.62 and its 200 day moving average is $36.61.

Analysts Set New Price Targets

USNA has been the topic of several research reports. StockNews.com lowered USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Sidoti lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, DA Davidson upped their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research note on Thursday, January 2nd.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.